Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity
Conditions: Breast Cancer Interventions: Drug: Dapagliflozin 10mg Tab Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Dapagliflozin | Forxiga | Heart | Research